Results 31 to 40 of about 1,651 (200)

Locoregional radionuclide therapy of glioblastoma with [211At]At-PDA-FAPI [PDF]

Scientific Reports
Glioblastoma is the most common and aggressive tumor of the central nervous system. Locoregional administration of therapeutic radiopharmaceuticals appears to be a promising modality for recurrent glioblastomas.
Huan Ma, Tianzhen Ye, Guofeng Qu, Yilin Qin, Jiali Liao, Yuanyou Yang, Wei Zhang, Ning Liu, Feize Li   +8 more
doaj   +2 more sources

Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization". [PDF]

Transplant Cell Ther, 2021
Nakaya A, Qiu H, Santos EB, Hamlin DK, Wilbur DS, Storb R, Sandmaier BM.   +6 more
europepmc   +3 more sources

Astatine-211 as an emerging radioisotope for Targeted Alpha Therapy (TAT) [PDF]

RAD Conference Proceedings
Cancer treatment presents complex challenges, necessitating the exploration of innovative approaches for diagnosis and therapy. Among emerging prospects, Radiopharmaceutical Therapy (RPT) using α- emitting radionuclides has gained notable attention. This
Apostolova, Paulina, Arev, Marija, Francois-Gestin, Jean, Janevik-Ivanovska, Emilija, Vranjes-Djuric, Sanja   +4 more
core   +4 more sources

Discussions on liquid bismuth target use as an alternative for astatine-211 production [PDF]

EPJ Web of Conferences, 2023
Astatine-211 is an alpha emitter that has been identified as a good candidate for targeted alpha therapy. There is an increasing demand on this radionuclide.
Bigourdan Théo, Cadiou Arnaud, Guertin Arnaud, Haddad Ferid   +3 more
doaj   +1 more source

Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets. [PDF]

Sci Rep, 2019
O'Hara MJ, Krzysko AJ, Hamlin DK, Li Y, Dorman EF, Wilbur DS.   +5 more
europepmc   +3 more sources

Production of Astatine-211 for U.S. Investigators

, 2012
D. Scott Wilbur
openalex   +4 more sources

Advances in 211At production at Texas A&M University [PDF]

EPJ Web of Conferences, 2021
Alpha emitting radionuclides with medically relevant half-lives are interesting for treatment of tumors and other diseases because they deposit large amounts of energy close to the location of the radioisotope.
Yennello S.J., McIntosh L.A, Burns J.D., Tereshatov E.E., Tabacaru G., McCann L., Schultz S., Lofton K., Abbott A., Avila G., Berko M., Engelthaler E., Hagel K., Hannaman A., Harvey B., Hood A., McCarthy M., McIntosh A.B., Sorensen M., Tobin Z, Vonder Haar A.   +20 more
doaj   +1 more source

Calculated astatine-211 production yields for radioimmunotherapy

Journal of Physics: Conference Series, 2018
Imam Kambali
openalex   +2 more sources

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model. [PDF]

Blood, 2015
Green DJ, Shadman M, Jones JC, Frayo SL, Kenoyer AL, Hylarides MD, Hamlin DK, Wilbur DS, Balkan ER, Lin Y, Miller BW, Frost SH, Gopal AK, Orozco JJ, Gooley TA, Laird KL, Till BG, Bäck T, Sandmaier BM, Pagel JM, Press OW.   +20 more
europepmc   +2 more sources

Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer [PDF]

EJNMMI Research
Lars Hvass, Marius Müller, Vladimir Shalgunov, Anne S. Clausen, Christian B. M. Poulie, Emma Aneheim, Holger J. Jensen, Matthias M. Herth, Andreas Kjaer   +8 more
doaj   +2 more sources